-+ 0.00%
-+ 0.00%
-+ 0.00%

BioForce NanoScience names Richard Kaiser interim CEO

PUBT·08/14/2026 19:27:00
Listen to the news
BioForce NanoScience names Richard Kaiser interim CEO
  • BioForce NanoScience created an advisory board on May 19, 2026, appointing private investor and former 3Point Capital Partners CEO Stuart Yarbrough.
  • Edward Mathias joined the advisory board; he is a senior advisor to Carlyle, former Carlyle executive, former T. Rowe Price management committee member.
  • Scott Mager was appointed general counsel on May 19, 2026; he is a corporate attorney and trial lawyer licensed in multiple states.
  • Mager also joined the board on June 15, 2026.
  • Richard Kaiser was named interim CEO on June 17, 2026; he has been an officer and director since July 1, 2013.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioForce Nanosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001091818-26-000124), on August 14, 2026, and is solely responsible for the information contained therein.